M16.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patient age between 65 and 85 years inclusive - Presence of arthrosis of the hip joint - Planned elective implantation of a total hip endoprosthesis - The patient must have the capacity to give consent - The patient must be able to participate in the in-house standard aftercare programme following hip replacement
Exclusion criteria
Exclusion criteria: - Pregnancy - Current malignant disease(s) - Radiation or chemotherapy in the 6 months prior to study entry (except preoperative radiation to prevent heterotopic ossification) - Current lymphatic drainage disorders of the lower extremity - Heart failure NYHA >=4 - History of drug abuse - Renal insufficiency with a GFR <=30ml/min - Liver cirrhosis (Child-Pugh C) - Acute skin florescence and parchment skin that do not allow application of Kinesiology Tape or AV Pulse System - Perioperative complications and secondary diseases that do not allow participation in the in-house standard follow-up treatment scheme after hip TEP
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Soft tissue swelling decrease in circumference measurements in cm | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative mobility, the VAS score | — |
Countries
Germany
Contacts
Waldkliniken Eisenberg; Klosterlausnitzer Straße 81; 07607 Eisenberg